Src kinase inhibitor compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/506 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 403/14 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2376951

Pyrimidine compounds (Formula I), or their pharmaceutically acceptable salts, hydrates, solvates, crystal forms and individual diastereomers, and pharmaceutical compositions including the same, which are inhibitors of tyrosine kinase enzymes, and as such are useful in the prophylaxis and treatment of protein tyrosine kinase-associated disorders, such as immune diseases, hyperproliferative disorders and other diseases in which inappropriate protein kinase action is believed to play a role, such as cancer, angiogenesis, atheroscelerosis, graft rejection, rheumatoid arthritis and psoriasis.

L'invention concerne des composés de pyrimidine (formule I), ou leurs sels acceptables pharmaceutiquement, des hydrates, des solvates, des formes de cristaux et des diastéréomères individuels, et des compositions pharmaceutiques contenant ceux-ci, qui sont des inhibiteurs des enzymes de tyrosine kinase, et qui en tant que tels sont utiles à la prophylaxie et au traitement de troubles liés à la protéine tyrosine kinase, tels que des maladies immunologiques, des troubles hyperprolifératifs et d'autres troubles. Dans ces maladies, l'action inappropriée de la protéine kinase est censée jouer un rôle, comme le cancer, l'angiogénèse, l'athérosclérose, le rejet de greffe, l'arthrite rhumatoïde et le psoriasis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Src kinase inhibitor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Src kinase inhibitor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Src kinase inhibitor compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1466708

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.